Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 447,700 shares, a growth of 412.2% from the December 31st total of 87,400 shares. Based on an average daily trading volume, of 2,936,800 shares, the short-interest ratio is currently 0.2 days.
Bayer Aktiengesellschaft Price Performance
Bayer Aktiengesellschaft stock traded down $0.07 during midday trading on Friday, reaching $5.64. 1,283,851 shares of the stock traded hands, compared to its average volume of 1,182,263. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. Bayer Aktiengesellschaft has a 12 month low of $4.79 and a 12 month high of $8.58. The stock's fifty day moving average is $5.17 and its 200-day moving average is $6.54. The stock has a market cap of $22.16 billion, a P/E ratio of -21.69 and a beta of 1.02.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by ($0.10). The business had revenue of $10.96 billion during the quarter. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. As a group, equities research analysts anticipate that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.
Bayer Aktiengesellschaft Company Profile
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
